<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2024 19_11-12_410</article-id>
<article-id pub-id-type="doi">10.15836/ccar2024.410</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
<subj-group subj-group-type="subheading"><subject>Arrhythmology and electrostimulation</subject></subj-group>
</article-categories>
<title-group>
<article-title>Significance of left atrial function in predicting early recurrence of atrial fibrillation following electrical cardioversion</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3749-6073</contrib-id><name><surname>&#x0160;abanovi&#x0107; Bajramovi&#x0107;</surname><given-names>Nirvana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4677-8489</contrib-id><name><surname>Iglica</surname><given-names>Amer</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1198-540X</contrib-id><name><surname>D&#x017E;ubur</surname><given-names>Alen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6842-262X</contrib-id><name><surname>Begi&#x0107;</surname><given-names>Edin</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3755-0968</contrib-id><name><surname>Vu&#x010D;ijak Grgurevi&#x0107;</surname><given-names>Marina</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9387-5081</contrib-id><name><surname>Bajramovi&#x0107;</surname><given-names>Senad</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<aff id="aff1"><label>1</label>Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina</aff>
<aff id="aff2"><label>2</label>General Hospital &#x2018;&#x2019;Prim.dr. Abdulah Naka&#x0161;&#x2019;&#x2019;, Sarajevo, Bosnia and Herzegovina</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Nirvana &#x0160;abanovi&#x0107; Bajramovi&#x0107;, Clinic for Heart, Blood Vessel and Rheumatic Diseases, Clinical Center University of Sarajevo; Bolni&#x010D;ka 25, 71000 Sarajevo, Bosnia and Herzegovina. / Phone: +38761361231 / E-mail: <email xlink:href="nirvana_sabanovic@yahoo.com">nirvana_sabanovic@yahoo.com</email></corresp></author-notes>
<pub-date date-type="pub" publication-format="electronic"><month>11</month><year>2024</year></pub-date>
<pub-date date-type="pub" publication-format="print"><month>11</month><year>2024</year></pub-date>
<volume>19</volume>
<issue>11-12</issue>
<fpage>410</fpage>
<lpage>410</lpage>
<history>
<date date-type="received"><day>07</day><month>10</month><year>2024</year></date>
<date><day>31</day><month>10</month><year>2024</year></date>
</history>
<permissions>
<copyright-statement>Croatian Cardiac Society</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>left atrial function</kwd><kwd>electrical cardioversion</kwd><kwd>atrial fibrillation recurrence</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Introduction</bold>: Left atrial (LA) mechanical dysfunction due to LA fibrosis, which is common in atrial fibrillation (AF) regardless of LA enlargement, can be assessed by LA strain. Important factor in determining which patients are more likely to experience an AF recurrence following cardioversion is among others the early detection of LA dysfunction. Predicting the likelihood of an AF recurrence prior to electrical cardioversion enables more effective patient selection and avoiding unnecessary risk and treatment costs. In addition, better selection of patients with high probability to FA recurrence enables us to manage more safely further drug treatment. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>-<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>) The main objective of this study was to assess whether LA function estimated by strain echocardiography carries any additional predictive significance for the early AF recurrence after electrical cardioversion.</p>
<p><bold>Patients and Methods</bold>: In total 36 symptomatic patients (EHRA symptom score &#x2265;3) with permanent atrial fibrillation and preserved systolic function who underwent successful electrical cardioversion were prospectively monitored. Following previous saturation with antiarrhythmic medications, successful electrical cardioversion was performed utilizing synchronized 200J energy to max three times. Mean age of patients was 49.8 &#x00B1; 5.3 years, 81% of them were male and 19% were female. Prior to cardioversion, a comprehensive echocardiography evaluation was carried out, including measuring the LA volume index and strain. As well TEE evaluation of the LAA was performed in each patient regardless of anticoagulant therapy status. The assessment of rhythm was carried out within the first month following cardioversion (33&#x00B1;3 days). Confirmation of the recurrence of persistent AF at the ambulatory control examination was the main outcome.</p>
<p><bold>Results</bold>: Regardless of the duration of AF, 12 patients (33,3%) of the total study population experienced an AF recurrence. The greatest incremental predictive value for an AF recurrence was found in patients with peak atrial longitudinal strain (PALS) &#x2264;17% (HR =7.37, 95% CI: 3.12&#x2013;19.25, p &lt; 0.001). PALS&#x2264;17% continued to be an independent predictor of AF recurrence in patients with non-dilated LA (HR = 5.23, 95% CI: 2.32&#x2013;15.71, p = 0.005).</p>
<p><bold>Conclusion</bold>: This study showed that LA function assessment using PALS can serve as an additional predictive marker for early recurrence of AF after electrical cardioversion independent of left atrial volume and AF duration. A better prediction of the early AF recurrence after electrical rhythm conversion allows a better selection of patients who undergo invasive treatment and can facilitate the decision of the clinician in tailoring the treatment strategy in terms of rate or rhythm control.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fornengo</surname><given-names>C</given-names></name><name><surname>Antolini</surname><given-names>M</given-names></name><name><surname>Frea</surname><given-names>S</given-names></name><name><surname>Gallo</surname><given-names>C</given-names></name><name><surname>Grosso Marra</surname><given-names>W</given-names></name><name><surname>Morello</surname><given-names>M</given-names></name><etal/></person-group> <article-title>Prediction of atrial fibrillation recurrence after cardioversion in patients with left-atrial dilation.</article-title> <source>Eur Heart J Cardiovasc Imaging</source>. <year>2015</year> March;<volume>16</volume>(<issue>3</issue>):<fpage>335</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1093/ehjci/jeu193</pub-id><pub-id pub-id-type="pmid">25274966</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>HT</given-names></name><name><surname>Lee</surname><given-names>HL</given-names></name><name><surname>Chou</surname><given-names>CC</given-names></name></person-group>. <article-title>From Left Atrial Dimension to Curved M-Mode Speckle-Tracking Images: Role of Echocardiography in Evaluating Patients with Atrial Fibrillation.</article-title> <source>Rev Cardiovasc Med</source>. <year>2022</year> May 11;<volume>23</volume>(<issue>5</issue>):<fpage>171</fpage>. <pub-id pub-id-type="doi">10.31083/j.rcm2305171</pub-id><pub-id pub-id-type="pmid">39077610</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohns</surname><given-names>C</given-names></name><name><surname>Marrouche</surname><given-names>NF</given-names></name></person-group>. <article-title>Atrial fibrillation and cardiac fibrosis.</article-title> <source>Eur Heart J</source>. <year>2020</year> March 7;<volume>41</volume>(<issue>10</issue>):<fpage>1123</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehz786</pub-id><pub-id pub-id-type="pmid">31713590</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
